Status:
RECRUITING
Patterns of Neurodevelopmental Disorders
Lead Sponsor:
Richard Frye
Collaborating Sponsors:
Autism Discovery and Treatment Foundation
Conditions:
Neurodevelopmental Disorders
Autism Spectrum Disorder
Eligibility:
All Genders
Brief Summary
The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Detailed Description
Although neurodevelopmental disorders are very prevalent (for example Autism affects 1 out of every 36 children and dyslexia affects up to 15% of the population), the etiology of such disorders is not...
Eligibility Criteria
Inclusion
- Neurodevelopmental delays Clinical visit at an Rossignol Medical Center
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06213090
Start Date
February 1 2024
End Date
December 31 2030
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rossignol Medical Center
Phoenix, Arizona, United States, 85050